Literature DB >> 26444260

Effects of smoking and alcohol use on neurocognitive functioning in heavy drinking, HIV-positive men who have sex with men.

Mollie A Monnig1, Christopher W Kahler1, Hana Lee2, David W Pantalone3,4, Kenneth H Mayer4,5, Ronald A Cohen6, Peter M Monti1.   

Abstract

High rates of cognitive impairment persist in human immunodeficiency virus (HIV) infection, despite improved health outcomes and reduced mortality through widespread use of antiretroviral therapy (ART). Heavy alcohol use and cigarette smoking are potential contributors to neurocognitive impairment in people living with HIV (PLWH), yet few studies have examined their influence concurrently. Here we investigated the effects of self-reported alcohol use and smoking on learning, memory, processing speed, verbal fluency, and executive function in 124 HIV-positive men who have sex with men [age (mean ± SD) = 42.8 ± 10.4 years], engaged with medical care. All participants were heavy drinkers. Duration of HIV infection averaged 9.9 ± 7.6 years, and 92.7% were on a stable ART regimen. Participants completed a neuropsychological battery and assessment of past 30-day substance use. Average number of drinks per drinking day (DPDD) was 5.6 ± 3.5, and 33.1% of participants were daily smokers. Rates of neurocognitive impairment were the highest in learning (50.8%), executive function (41.9%), and memory (38.0%). Multiple regression models tested DPDD and smoking status as predictors of neurocognitive performance, controlling for age and premorbid intelligence. Smoking was significantly, negatively related to verbal learning (p = .046) and processing speed (p = .001). DPDD was a significant predictor of learning (p = .047) in a model that accounted for the interaction of DPDD and smoking status. As expected, premorbid intelligence significantly predicted all neurocognitive scores (ps < .01), and older age was associated with slower processing speed (ps < .01). In conclusion, smoking appears to be associated with neurocognitive functioning deficits in PLWH beyond the effects of heavy drinking, aging, and premorbid intelligence. Smoking cessation interventions have the potential to be an important target for improving functional outcomes in heavy drinking PLWH.

Entities:  

Keywords:  Smoking; alcohol; cognition; human immunodeficiency virus (HIV); processing speed

Mesh:

Year:  2015        PMID: 26444260      PMCID: PMC4821065          DOI: 10.1080/09540121.2015.1093595

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  19 in total

1.  Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.

Authors:  R A Cohen; R Boland; R Paul; K T Tashima; E E Schoenbaum; D D Celentano; P Schuman; D K Smith; C C Carpenter
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

2.  Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

Authors:  Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

3.  Initial validation of a screening battery for the detection of HIV-associated cognitive impairment.

Authors:  Catherine L Carey; Steven Paul Woods; Julie D Rippeth; Raul Gonzalez; David J Moore; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  Clin Neuropsychol       Date:  2004-05       Impact factor: 3.535

4.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

Authors:  J T Sullivan; K Sykora; J Schneiderman; C A Naranjo; E M Sellers
Journal:  Br J Addict       Date:  1989-11

5.  The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

Authors:  R K Heaton; I Grant; N Butters; D A White; D Kirson; J H Atkinson; J A McCutchan; M J Taylor; M D Kelly; R J Ellis
Journal:  J Int Neuropsychol Soc       Date:  1995-05       Impact factor: 2.892

6.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

7.  Neurocognitive performance and quality of life in patients with HIV infection.

Authors:  Valerio Tozzi; Pietro Balestra; Simonetta Galgani; Rita Murri; Rita Bellagamba; Pasquale Narciso; Andrea Antinori; Marinella Giulianelli; Gherardo Tosi; Marina Costa; Alessandro Sampaolesi; Massimo Fantoni; Pasquale Noto; Giuseppe Ippolito; Albert W Wu
Journal:  AIDS Res Hum Retroviruses       Date:  2003-08       Impact factor: 2.205

Review 8.  Mechanisms of neurodegeneration and regeneration in alcoholism.

Authors:  Fulton T Crews; Kim Nixon
Journal:  Alcohol Alcohol       Date:  2008-10-21       Impact factor: 2.826

Review 9.  Controversies in HIV-associated neurocognitive disorders.

Authors:  Sam Nightingale; Alan Winston; Scott Letendre; Benedict D Michael; Justin C McArthur; Saye Khoo; Tom Solomon
Journal:  Lancet Neurol       Date:  2014-11       Impact factor: 44.182

10.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.

Authors:  Robert K Heaton; Donald R Franklin; Ronald J Ellis; J Allen McCutchan; Scott L Letendre; Shannon Leblanc; Stephanie H Corkran; Nichole A Duarte; David B Clifford; Steven P Woods; Ann C Collier; Christina M Marra; Susan Morgello; Monica Rivera Mindt; Michael J Taylor; Thomas D Marcotte; J Hampton Atkinson; Tanya Wolfson; Benjamin B Gelman; Justin C McArthur; David M Simpson; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Terry L Jernigan; Joseph Wong; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-21       Impact factor: 2.643

View more
  17 in total

1.  Is successful HIV therapy a Pyrrhic victory for the brain?

Authors:  David B Clifford
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

2.  Perceptions of Brain Health and Cognition in Older African Americans and Caucasians With HIV: A Focus Group Study.

Authors:  David E Vance; C Ann Gakumo; Gwendolyn D Childs; Comfort Enah; Pariya L Fazeli
Journal:  J Assoc Nurses AIDS Care       Date:  2017-07-26       Impact factor: 1.354

3.  The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.

Authors:  Joseph D Harrison; Jessica A Dochney; Sonja Blazekovic; Frank Leone; David Metzger; Ian Frank; Robert Gross; Anita Hole; Karam Mounzer; Steven Siegel; Robert A Schnoll; Rebecca L Ashare
Journal:  J Neurovirol       Date:  2017-04-20       Impact factor: 2.643

Review 4.  Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

5.  Association of midlife smoking status with change in processing speed and mental flexibility among HIV-seropositive and HIV-seronegative older men: the Multicenter AIDS Cohort Study.

Authors:  Wajiha Z Akhtar-Khaleel; Robert L Cook; Steve Shoptaw; Eric N Miller; Ned Sacktor; Pamela J Surkan; Jim Becker; Linda A Teplin; Rebecca J Beyth; Catherine Price; Michael Plankey
Journal:  J Neurovirol       Date:  2016-11-26       Impact factor: 2.643

Review 6.  Neurologic Complications of Human Immunodeficiency Virus Infection.

Authors:  Deanna Saylor
Journal:  Continuum (Minneap Minn)       Date:  2018-10

Review 7.  Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.

Authors:  Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-13       Impact factor: 4.147

8.  Heavy Alcohol Use and Age Effects on HIV-Associated Neurocognitive Function.

Authors:  Ronald A Cohen; Joseph M Gullett; Eric C Porges; Adam J Woods; Damon G Lamb; Vaughn E Bryant; Mikayla McAdams; Karen Tashima; Robert Cook; Kendall Bryant; Mollie Monnig; Christopher W Kahler; Peter M Monti
Journal:  Alcohol Clin Exp Res       Date:  2018-12-16       Impact factor: 3.455

9.  A Modified Alcohol SBI for Use among Older Adults Living with HIV.

Authors:  Annie L Nguyen; Jordan E Lake; Diane Preciado; Diana Liao; Alison A Moore; Homero E Del Pino
Journal:  West J Nurs Res       Date:  2020-04-02       Impact factor: 1.967

10.  No differences in delay discounting between smokers with and without HIV.

Authors:  Cory Czuczman; Morgan Thompson; E Paul Wileyto; Robert Schnoll; David Metzger; Frank Leone; Karam Mounzer; Robert Gross; Rebecca L Ashare
Journal:  Psychopharmacology (Berl)       Date:  2020-11-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.